从1990年到2019年,多抗药结核病的全球流行率和负担
Hengliang Lv1,2, Xin Zhang1,2, Xueli Zhang3
1Department of Epidemiology, School of Public Health, China Medical University, Shenyang, China.
BMC infectious diseases
|February 22, 2024
概括
耐多药结核病 (MDR-TB) 仍然是一个重大的全球健康威胁. 这项研究显示,从1990年到2019年,结核病发病率,流行率和死亡率都在上升,这凸显了迫切需要采取全球行动来减少结核病负担.
科学领域:
- 流行病学 流行病学
- 公共卫生 公共卫生
- 传染性疾病 传染性疾病
背景情况:
- 结核病 (TB) 构成了重大的全球卫生挑战,多药耐药结核病 (MDR-TB) 构成了关键威胁.
- 可靠的流行病学数据对于有效的公共卫生战略对抗MDR-TB至关重要.
研究的目的:
- 对MDR-TB的全球流行和负担进行全面的流行病学评估.
- 分析1990年至2019年的MDR-TB的趋势.
主要方法:
- 利用了来自2019年全球疾病负担 (GBD) 数据库的数据.
- 估计的年龄标准化流行,发病率,残疾调整寿命年 (DALYs) 和死亡率.
- 使用Joinpoint回归分析时间趋势,计算年平均百分比变化 (AAPC).
主要成果:
- 2019年,全球MDR-TB估计包括687,839例病例,非洲和东南亚的负担显著.
- 与女性相比,男性的MDR-TB流行率,DALY和死亡率较高,且随着年龄的增长而增加.
- 从1990年到2019年,在MDR-TB发病率 (AAPC=5.8%),流行率 (AAPC=5.9%),DALYs (AAPC=4.6%) 和死亡率 (AAPC=4.4%) 中观察到全球显著增加.
结论:
- 这项研究证实了耐药结核病对公众健康的持续和日益增长的威胁.
- 需要采取紧急,协调的全球行动,以实施有效的措施来减少MDR-TB负担.
相关概念视频
Pulmonary Tuberculosis V
180
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
180
Pulmonary Tuberculosis I
243
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
243
Pulmonary Tuberculosis IV
143
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
143
Pulmonary Tuberculosis II
236
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
236
Pulmonary Tuberculosis III
326
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
326
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K


